IL6 and cardiac arrhythmia: Patient 2 exhibited symptoms of acute heart failure and arrhythmia associated with clinical manifestations of VEXAS syndrome (eg, skin lesions, chondritis), which were managed with heart failure treatment and antiarrhythmic agents, alongside interleukin 6 inhibitor tocilizumab and corticosteroids; other VEXAS symptoms were stabilized.